What is Artiva Biotherapeutics, Inc.'s net margin?

Artiva Biotherapeutics, Inc. (ARTV) reported net margin of -79.3% in Q1 2024.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Artiva Biotherapeutics, Inc. ARTV Net margin

Net margin at other companies

Bristol-Myers SquibbBMY

15%+3.8pp

Gilead SciencesGILD

31%+10.2pp

Allogene TherapeuticsALLO

-1,170,863.6%-2,007,890pp

ImmunityBio, Inc.IBRX

-606.2%-212pp

Nektar TherapeuticsNKTR

-284.2%+937pp

Avalo TherapeuticsAVTX

-7,965.8%-10,750pp

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Calculated from Artiva Biotherapeutics, Inc.’s reported figures.

net income/total revenue=-79.3%

Based on trailing twelve months.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2025, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s net margin?: Artiva Biotherapeutics, Inc. (ARTV) reported net margin of -79.3% in Q1 2024.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.